|
Manufacturers / Sponsors
- Novo Nordisk (liraglutide)
Patient / carer Groups
- Afiya Trust
- Age Concern & Help the Aged
- Black & Ethnic Minority Diabetes Association (BEMDA)
- Black Health Agency
- Chinese National Healthy Living Centre
- Confederation of Indian Organisations
- Counsel and Care
- Diabetes Research & Wellness Foundation
- Diabetes UK
- Equalities National Council
- Muslim Council of Great Britain
- Muslim Health Network
- National Obesity Forum (Added – 30/9/09)
- Network of Sikh Organisations
- South Asian Health Foundation
- Specialised Healthcare Alliance
- Surya Foundation
Professional groups
- Association of British Clinical Diabetologists
- British Association for Services to the Elderly
- British Geriatrics Society
- Diabetes Monitoring Forum
- National Diabetes Nurse Consultant Group (previously Association of Diabetes Specialist Nurses – 19/8/09)
- Primary Care Diabetes UK
- Royal College of General Practitioners
- Royal College of Nursing
- Royal College of Pathologists
- Royal Collegeof Physicians
- Royal Pharmaceutical Society
- Royal Society of Medicine – Intellectual Disabilities Forum
- United Kingdom Clinical Pharmacy Association
- British Diabetics Association (removed – same as Diabetes UK – 19/8/09)
Others
- Department of Health
- NorfolkPCT
- Welsh Assembly Government
- West SussexTeaching PCT
|
General
- Board of Community Health Councils in Wales
- British National Formulary
- Diabetes UK Cymru
- Department of Health, Social Services and Public Safety for Northern Ireland
- Medicines and Healthcare products Regulatory Agency (MHRA)
- National Association of Primary Care
- National Public Health Service for Wales
- NHS Alliance
- NHS Confederation
- NHS Purchasing and Supply Agency
- NHS Quality Improvement Scotland
- Scottish Medicines Consortium
Comparator manufacturer(s)
- Actavis UK (gliclazide)
- Actavis (glimepiride, tolbutamide)
- Daiichi-Sankyo (repaglinide)
- Eli Lilly (exenatide)
- GSK (metformin/rosiglitazone, rosiglitazone)
- Hoechst Marion Roussel (glimepiride)
- Lilly (Humulin, Humalog)
- Merck (metformin)
- Merck, Sharp and Dohme (sitagliptin)
- Novartis (metformin, vildagliptin, nateglinide)
- Novo Nordisk (Actrapid, Velosulin, Novorapid, Levemir, Insulatard, NovoMix, Mixtard)
- Pfizer (glipizide)
- Rosemont Pharmaceuticals(metformin)
- Sanofi-aventis (Apidra, gliquidone, glibenclamide, glimepiride, Insuman, Lantus)
- Servier (gliclazide)
- Takeda (metformin, pioglitazone)
- Wockhardt (metformin,Hypurin, glibenclamide)
Relevant research groups
- Diabetes Foundation
- Heart Disease & Diabetes Research Trust
- MRC Clinical Trials Unit
- National Institute for Health Research
- Policy Research Institute on Ageing and Ethnicity
- Research Institute for the Care of Older People
Evidence Review Group
- Aberdeen HTA Group
- National Institute for Health Research Health Technology Assessment Programme
Associated Guideline Groups
Associated Public Health Groups
|
